Abstract:Abstract Hypertension in midlife contributes to cognitive decline and is a modifiable risk factor for dementia. The relationship between late-life hypertension and dementia is less clear. We have investigated the relationship of blood pressure and hypertensive status during late life (after 65 years) to post-mortem markers of Alzheimer’s disease (amyloid-β and tau loads); arteriolosclerosis and cerebral amyloid angiopathy; and to biochemical measures of ante-mortem cerebral oxygenation (the myelin-associated glycoprotein:proteolipid protein-1 ratio, which is reduced in chronically hypoperfused brain tissue, and the level of vascular endothelial growth factor-A, which is upregulated by tissue hypoxia); blood–brain barrier damage (indicated by an increase in parenchymal fibrinogen); and pericyte content (platelet-derived growth factor receptor β, which declines with pericyte loss), in Alzheimer’s disease (n = 75), vascular (n = 20) and mixed dementia (n = 31) cohorts. Systolic and diastolic blood pressure measurements were obtained retrospectively from clinical records. Non-amyloid small vessel disease and cerebral amyloid angiopathy were scored semiquantitatively. Amyloid-β and tau loads were assessed by field fraction measurement in immunolabelled sections of frontal and parietal lobes. Homogenates of frozen tissue from the contralateral frontal and parietal lobes (cortex and white matter) were used to measure markers of vascular function by enzyme-linked immunosorbent assay. Diastolic (but not systolic) blood pressure was associated with the preservation of cerebral oxygenation, correlating positively with the ratio of myelin-associated glycoprotein to proteolipid protein-1 and negatively with vascular endothelial growth factor-A in both the frontal and parietal cortices. Diastolic blood pressure correlated negatively with parenchymal amyloid-β in the parietal cortex. In dementia cases, elevated late-life diastolic blood pressure was associated with more severe arteriolosclerosis and cerebral amyloid angiopathy, and diastolic blood pressure correlated positively with parenchymal fibrinogen, indicating blood–brain barrier breakdown in both regions of the cortex. Systolic blood pressure was related to lower platelet-derived growth factor receptor β in controls in the frontal cortex and in dementia cases in the superficial white matter. We found no association between blood pressure and tau. Our findings demonstrate a complex relationship between late-life blood pressure, disease pathology and vascular function in dementia. We suggest that hypertension helps to reduce cerebral ischaemia (and may slow amyloid-β accumulation) in the face of increasing cerebral vascular resistance, but exacerbates vascular pathology.

Blood Pressure is Associated with Higher Brain Amyloid Burden and Lower Glucose Metabolism in Healthy Late Middle-Age Persons

Elevated late-life blood pressure may maintain brain oxygenation and slow amyloid-β accumulation at the expense of cerebral vascular damage

Higher Arterial Stiffness but Not Blood Pressure is Associated with Brain Amyloidosis and Preclinical AD in Healthy Adults: Results from the Emory Healthy Brain Study

Higher Serum Total Cholesterol Levels in Late Middle Age Are Associated with Glucose Hypometabolism in Brain Regions Affected by Alzheimer'S Disease and Normal Aging

Blood pressure interacts with APOE ε4 to predict memory performance in a midlife sample.

Blood Pressure Level Is Associated With Changes in Plasma Aβ1 –40 and Aβ1–42 Levels: A Cross-sectional Study Conducted in the Suburbs of Xi’an, China

P2‐300: THE BLOOD PRESSURE LEVEL IS ASSOCIATED WITH PLASMA AMYLOID‐β LEVELS: A CROSS‐SECTIONAL STUDY IN THE SUBURBS OF XI'AN, CHINA

Blood Pressure, Antihypertensive Use, and Late-Life Alzheimer and Non-Alzheimer Dementia Risk: An Individual Participant Data Meta-Analysis

Late-Life Blood Pressure and Cerebral Amyloid Angiopathy: Findings from the U.S. National Alzheimer's Coordinating Center Uniform Dataset

Cumulative Blood Pressure Exposure, Basal Ganglia, and Thalamic Morphology in Midlife

P2‐243: Higher BMI is Associated with Greater Cerebral Glucose Metabolism in Late Middle‐Aged and Elderly Subjects Regardless of APOE Ε4 Genotype

Association of Blood Pressure With Brain Ages: A Cohort Study of Gray and White Matter Aging Discrepancy in Mid-to-Older Adults From UK Biobank

HIGHER BMI IS ASSOCIATED WITH GREATER CEREBRAL GLUCOSE METABOLISM IN LATE MIDDLE-AGED AND ELDERLY SUBJECTS REGARDLESS OF APOE ε4 GENOTYPE

Sex-Dependent Effects of Cardiometabolic Health and APOE4 on Brain Age: A Longitudinal Cohort Study

Investigating the Association Between Fasting Serum Glucose Levels and Cerebral Metabolic Rate for Glucose in Brain Regions Affected by Alzheimer's Disease

Anti-Hypertensive Drugs Moderate the Relationship of Blood Pressure with Alzheimer’s Pathologies and Neurodegenerative Markers in Non-Demented Hypertensive Older Adults

Blood Pressure Control in Aging Predicts Cerebral Atrophy Related to Small-Vessel White Matter Lesions.

Association Between Higher Fasting Serum Glucose Levels and the Pattern of Lower Regional Gray Matter Volumes in Cognitively Normal Adults

P1‐436: EFFECT OF APOE Ε4 ON BRAIN STRUCTURE AND FUNCTION IN THE TEMPORAL REGIONS IN ELDERLY INDIVIDUALS WITH HYPERTENSION

Diabetes and hypertension are related to amyloid-beta burden in the population-based Rotterdam Study

Association Between Cerebral Patterns of Fibrillar Beta-Amyloid Burden and Glucose Hypometabolism in Cognitively Normal Older Adults at Three Levels of Genetic Risk for Late-Onset Alzheimer's Disease